These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2572259

  • 1. Effect of xamoterol on peripheral blood vessels in healthy subjects.
    Fitzgerald DE.
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):70S-72S. PubMed ID: 2572259
    [Abstract] [Full Text] [Related]

  • 2. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
    Fitzgerald DE, Harry JD.
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
    [Abstract] [Full Text] [Related]

  • 3. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.
    Tangø M, Carlsen JE, Trap-Jensen J.
    Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963
    [Abstract] [Full Text] [Related]

  • 4. The electrophysiological effects of intravenous xamoterol in man.
    Bowes RJ, Gautam PC, Graham DR, Harley A.
    Eur J Clin Pharmacol; 1986; 29(6):731-4. PubMed ID: 2872057
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 6. The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
    McCaffrey PM, Riddell JG, Shanks RG.
    J Cardiovasc Pharmacol; 1988 May; 11(5):543-51. PubMed ID: 2455840
    [Abstract] [Full Text] [Related]

  • 7. Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
    McCaffrey PM, Riddell JG, Shanks RG.
    Eur Heart J; 1990 Apr; 11 Suppl A():54-5. PubMed ID: 1971592
    [Abstract] [Full Text] [Related]

  • 8. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
    Jakubetz J, Schmuck S, Poller U, Fuchs B, Gorf A, Radke J, Pönicke K, Brodde OE.
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):461-72. PubMed ID: 10069683
    [Abstract] [Full Text] [Related]

  • 9. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
    Tomlinson B, Cruickshank JM, Hayes Y, Renondin JC, Lui JB, Graham BR, Jones A, Lewis AD, Prichard BN.
    Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.
    Sørensen EV, Jensen HK, Faergeman O.
    Eur J Clin Pharmacol; 1991 Nov; 41(1):51-5. PubMed ID: 1685993
    [Abstract] [Full Text] [Related]

  • 11. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.
    Hashimoto T, Shiina A, Toyo-Oka T, Hosoda S, Kondo K.
    Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y, Sakuma I, Nakao Y, Kanno M.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [Abstract] [Full Text] [Related]

  • 13. Myocardial, coronary, and peripheral effects of xamoterol (ICI 118,587) in open-chest pigs.
    Galiè N, Metalli M, Zannoli R, Binetti G, Branzi A, Magnani B.
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):91-7. PubMed ID: 2577281
    [Abstract] [Full Text] [Related]

  • 14. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ, Davies MK.
    Br J Clin Pharmacol; 1989 Mar; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [Abstract] [Full Text] [Related]

  • 15. Effects of xamoterol on sodium excretion in volunteers.
    Zech PY, Pozet N, Day MA, Snow HM, Madonna O, Hadj-Aissa A.
    Br J Clin Pharmacol; 1989 Mar; 28 Suppl 1(Suppl 1):89S-91S. PubMed ID: 2572266
    [Abstract] [Full Text] [Related]

  • 16. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
    Virk SJ, Anfilogoff NH, Lawson N, Sadler AM, Smith SJ, Nuttall A, Murray RG, Littler WA, Davies MK.
    Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233
    [Abstract] [Full Text] [Related]

  • 17. Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.
    Rousseau MF, Pouleur H, Debaisieux JC, Van Eyll C, Charlier AA.
    Br J Clin Pharmacol; 1989 Mar; 28 Suppl 1(Suppl 1):84S-85S. PubMed ID: 2572264
    [Abstract] [Full Text] [Related]

  • 18. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
    Brodde OE, Daul A, Michel-Reher M, Boomsma F, Man in 't Veld AJ, Schlieper P, Michel MC.
    Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of xamoterol after intravenous and oral administration to volunteers.
    Bastain W, Boyce MJ, Stafford LE, Morton PB, Clarke DA, Marlow HF.
    Eur J Clin Pharmacol; 1988 Mar; 34(5):469-73. PubMed ID: 2904884
    [Abstract] [Full Text] [Related]

  • 20. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
    Lammers JW, Müller ME, Folgering HT, van Herwaarden CL.
    Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.